Cargando…
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy. Although novel emerging drugs are available, the overall prognosis remains poor and new therapeutic approaches are required. PP2A phosphatase is a key regulator of cell homeostasis and is recurrently inactivated in AML. The antica...
Autores principales: | Arriazu, Elena, Vicente, Carmen, Pippa, Raffaella, Peris, Irene, Martínez-Balsalobre, Elena, García-Ramírez, Patricia, Marcotegui, Nerea, Igea, Ana, Alignani, Diego, Rifón, José, Mateos, María C., Cayuela, María L., Nebreda, Angel R., Odero, María D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949222/ https://www.ncbi.nlm.nih.gov/pubmed/31913266 http://dx.doi.org/10.1038/s41408-019-0270-0 |
Ejemplares similares
-
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
por: Arriazu, Elena, et al.
Publicado: (2016) -
MYC-dependent recruitment of RUNX1 and GATA2 on the SET oncogene promoter enhances PP2A inactivation in acute myeloid leukemia
por: Pippa, Raffaella, et al.
Publicado: (2016) -
Set Protein Is Involved in FLT3 Membrane Trafficking
por: Marcotegui, Nerea, et al.
Publicado: (2023) -
The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias
por: Pippa, Raffaella, et al.
Publicado: (2020) -
Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia
por: García-Ortí, Laura, et al.
Publicado: (2012)